Skip to content

PHARMALEX

Active
Private limited companyfounded 200026 yrs activeRue de Mulhouse 33, 4020 Liège, BelgiumKBO/BCE: BE 0471.925.883
Summary

PHARMALEX has been active since 2000 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.9m and a net result of €64,882. Equity remains stable across the filed fiscal years (±2.3% per year). Its solvency ranks better than 88% of 1007 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability72▼-5
Solvency100=
Growth52=
Track record100
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €160,000 at 30 days acceptable
Liquidity ample (current ratio 6.37 against 4.01 in 2024; short-term debt: 15.7% and cash: 19% of total assets), and 15.7% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 69
Relative position
BE, all sectors
reference
Legal and accounting activities (NACE 69)
about 77% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 26 years 0 30 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
84.3%
Return on assets
2.9%
Age of the figures
15 mo
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 08-01-2026, 23 days ahead of the deadline.
NBB · 9 filings
Deviation from the deadline
2025
23 d early
2024
43 d early
2023
6 d early
2022
39 d early
2021
125 d early
2020
61 d early
2019
15 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 45 days before the deadline; the sector median for financial year 2024 is 9 days before the deadline, and 32% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
30-06-2026 close27-09-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

PHARMALEX was incorporated on 19 May 2000.1 Since 2026, AMARRIS HOLDING.BE has served as non-statutory director of the company.2 Total assets went from EUR 2.5 million in 2018 to EUR 2.3 million in 2025 and headcount from 11.3 to 15 full-time equivalents.3

  1. 1Crossroads Bank for Enterprises
  2. 2Belgian State Gazette, 03-08-2026
  3. 3National Bank, annual accounts 2018 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, full schema

Turnover
€1.9m
EBIT margin
25.5%
Net result
€64,882▼ 62.7%
2024 · €174,155
Working capital
€1.9m▲ 1.1%
2024 · €1.9m
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 69, Legal and accounting activities, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Turnover€1.9m
Operating result€914,870▲ 26.1%€237,180▼ 74.1%€477,599▲ 101%€252,832▼ 47.1%€88,406▼ 65.0%
Net result€705,655above the sector's middle half▲ 39.1%€176,576within the sector's middle half▼ 75.0%€368,819above the sector's middle half▲ 109%€174,155within the sector's middle half▼ 52.8%€64,882within the sector's middle half▼ 62.7%
EBIT margin25.5%
Equity€1.9mabove the sector's middle half▼ 2.1%€1.9mabove the sector's middle half▼ 1.1%€1.9mabove the sector's middle half€1.9mabove the sector's middle half▲ 1.0%
Total assets€2.9mabove the sector's middle half▼ 3.4%€2.4mabove the sector's middle half▼ 17.2%€2.6mwithin the sector's middle half▲ 7.9%€2.5mabove the sector's middle half▼ 1.4%€2.3mwithin the sector's middle half▼ 10.0%
Debt€942,415▼ 6.0%€471,844▼ 49.9%€593,509▲ 25.8%€626,802▲ 5.6%€356,010▼ 43.2%
Working capital€1.9m▼ 3.1%€1.1m▼ 42.5%€1.2m▲ 4.8%€1.9m▲ 62.9%€1.9m▲ 1.1%
Solvency67.1%above the sector's middle half▲ 0.9pp80.1%above the sector's middle half▲ 13.0pp75.2%above the sector's middle half84.3%above the sector's middle half▲ 9.2pp
Staff (FTE)10.7above the sector's middle half▼ 10.8%12.3above the sector's middle half14.8above the sector's middle half▲ 20.3%15above the sector's middle half▲ 1.4%
above within below the middle half (P25 to P75) of NACE 69, Legal and accounting activities, each year against the same schema; no band under 30 filings.
Why a figure moved sharply
  • 2024 Net result -53% on 2023. The accounts now follow the full schema, last year the abbreviated schema.
  • 2023 Net result +109% on 2022. The previous fiscal year ran 6 months, this one 12. The accounts now follow the abbreviated schema, last year the full schema.
  • 2022 Net result -75% on 2021. This fiscal year ran 6 months, the previous one 12.
Result per fiscal year
Operating resultNet result
€0€250,000€500,000€750,000€1.0mOperating result 2021: €914,870€914,870Net result 2021: €705,655€705,655Operating result 2022: €237,180€237,180Net result 2022: €176,576€176,576Operating result 2023: €477,599€477,599Net result 2023: €368,819€368,819Operating result 2024: €252,832€252,832Net result 2024: €174,155€174,155Operating result 2025: €88,406€88,406Net result 2025: €64,882€64,88220212022202320242025€0€200,000€400,000Operating result 2023: €477,599€478,000Net result 2023: €368,819€369,000Operating result 2024: €252,832€253,000Net result 2024: €174,155€174,000Operating result 2025: €88,406€88,400Net result 2025: €64,882€64,900202320242025
The operating result has fallen two years in a row; 2025 is 65% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.3m
Fixed assets €5,790 ▼ 21.1%
Current assets €2.3m ▼ 9.9%
Equity and liabilities €2.3m
Equity €1.9m ▲ 1.0%
Debt €356,010 ▼ 43.2%
Debt's share of the balance-sheet total falls from 24.8% to 15.7%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€89,954▼
2024 · €254,343
Cash flow
€66,430▼
2024 · €175,667
Current ratio
6.37▲
2024 · 4.01
Debt to equity
0.19▼
2024 · 0.33
ROE
3.4%▼
2024 · 9.2%
ROA
2.9%▼
2024 · 6.9%
Interest coverage
32.24▼
2024 · 54.19
Debt ≤ 1 year
€356,010▼
2024 · €626,802
Income taxes
€34,079▼
2024 · €82,028
Staff costs
€1.1m▲
2024 · €960,238
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 14,684 companies that looked in July 2024 the way this one looks now, 0.2% went bankrupt within 24 months and 96% are still going.

  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit under 5% of the balance sheet
0.2% went bankrupt
3.5% stopped otherwise
96% still going

A further 0.2% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.6%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 14,684 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 55 lines
Balance sheet Code20242025
Assets
Total assets20/58€2.5m€2.3m▼
Fixed assets21/28€7,338€5,790▼
Tangible fixed assets22/27€7,338€5,790▼
Plant, machinery and equipment23€2,415€2,151▼
Furniture and vehicles24€4,923€3,639▼
Current assets29/58€2.5m€2.3m▼
Amounts receivable within one year40/41€2.2m€1.8m▼
Trade receivables40€939,768€628,309▼
Other amounts receivable41€1.2m€1.2m▼
Cash at bank and in hand54/58€322,352€431,662▲
Deferred charges and accrued income490/1€14,004€30,369▲
Equity and liabilities
Total equity and liabilities10/49€2.5m€2.3m▼
Equity10/15€1.9m€1.9m▲
Contributions10/11€18,600€18,600=
Reserves13€1.9m€1.9m▲
Non-distributable reserves130/1€800,000€800,000=
Reserves not available under the articles1311€800,000€800,000=
Tax-exempt reserves132€126,300€159,407▲
Distributable reserves133€931,400€931,400=
Profit (loss) carried forward14€20,794€7,065▼
Amounts payable17/49€626,802€356,010▼
Amounts payable within one year42/48€626,802€356,010▼
Trade debts44€240,640€107,734▼
Suppliers440/4€240,132€107,734▼
Bills of exchange payable441€507-
Advances received on contracts in progress46€1,621-
Taxes, remuneration and social security45€141,522€202,773▲
Taxes450/3€41,364€51,789▲
Remuneration and social security454/9€100,159€150,984▲
Other amounts payable47/48€243,019€45,504▼
Income statement Code20242025
Remuneration, social security and pensions62€960,238€1.1m▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1,512€1,548▲
Other operating charges640/8€975€6,112▲
Non-recurring operating charges66A-€3,000
Gross operating margin9900€1.2m€1.2m▼
Operating profit (loss)9901€252,832€88,406▼
Financial income75/76B€8,045€13,345▲
Recurring financial income75€8,045€13,345▲
Financial charges65/66B€4,693€2,790▼
Recurring financial charges65€4,693€2,790▼
Profit (loss) for the period before taxes9903€256,183€98,961▼
Income taxes67/77€82,028€34,079▼
Profit (loss) for the period9904€174,155€64,882▼
Transfer from tax-exempt reserves789€89,000-
Transfer to tax-exempt reserves689€63,150€33,107▼
Profit (loss) for the period to be appropriated9905€200,005€31,775▼
Appropriation of the result
Profit (loss) to be appropriated9906€202,813€52,569▼
Profit (loss) brought forward from the previous period14P€2,808€20,794▲
Transfer from equity791/2€150,000-
Transfer to equity691/2€89,000-
To other reserves6921€89,000-
Profit to be distributed694/7€243,019€45,504▼
Return on contributions (dividend)694€200,000-
Employees696€43,019€45,504▲
Social balance
Average headcount (FTE)908714.815.0▲

The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Turnover70--€1.9m---
Goods, raw materials, services and sundry goods60/61--€640,802---
Remuneration, social security and pensions62-€358,515€754,854€960,238€1.1m▲ 10.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€454€227€484€1,512€1,548▲ 2.4%
Other operating charges640/8-€36€1,080€975€6,112▲ 527%
Non-recurring operating charges66A----€3,000-
Gross operating margin9900€1.5m€595,958€1.2m€1.2m€1.2m▼ 4.9%
Operating profit (loss)9901€914,870€237,180€477,599€252,832€88,406▼ 65.0%
Financial income75/76B-€2,156€9,515€8,045€13,345▲ 65.9%
Recurring financial income75€62,308€2,156€9,515€8,045€13,345▲ 65.9%
Financial charges65/66B-€665€1,447€4,693€2,790▼ 40.6%
Recurring financial charges65€28,568€665€1,447€4,693€2,790▼ 40.6%
Profit (loss) for the period before taxes9903€948,014€238,672€485,667€256,183€98,961▼ 61.4%
Income taxes67/77€242,359€62,096€116,848€82,028€34,079▼ 58.5%
Profit (loss) for the period9904€705,655€176,576€368,819€174,155€64,882▼ 62.7%
Transfer from tax-exempt reserves789-€44,500€101,040€89,000--
Transfer to tax-exempt reserves689--€63,150€63,150€33,107▼ 47.6%
Profit (loss) for the period to be appropriated9905€767,655€221,076€406,709€200,005€31,775▼ 84.1%
Line20212022202320242025Change
Assets
Total assets20/58€2.9m€2.4m€2.6m€2.5m€2.3m▼ 10.0%
Fixed assets21/28€499€800,272€806,206€7,338€5,790▼ 21.1%
Tangible fixed assets22/27€499€272€6,206€7,338€5,790▼ 21.1%
Plant, machinery and equipment23---€2,415€2,151▼ 10.9%
Furniture and vehicles24-€272€6,206€4,923€3,639▼ 26.1%
Financial fixed assets28-€800,000€800,000---
Current assets29/58€2.9m€1.6m€1.8m€2.5m€2.3m▼ 9.9%
Amounts receivable within one year40/41€584,901€780,443€1.3m€2.2m€1.8m▼ 17.2%
Trade receivables40-€735,640€747,873€939,768€628,309▼ 33.1%
Other amounts receivable41-€44,803€582,528€1.2m€1.2m▼ 5.2%
Cash at bank and in hand54/58€2.3m€774,627€406,925€322,352€431,662▲ 33.9%
Deferred charges and accrued income490/1-€16,679€15,935€14,004€30,369▲ 117%
Equity and liabilities
Total equity and liabilities10/49€2.9m€2.4m€2.6m€2.5m€2.3m▼ 10.0%
Equity10/15€1.9m€1.9m-€1.9m€1.9m▲ 1.0%
Contributions10/11-€18,600€18,600€18,600€18,600=
Reserves13€1.9m€1.9m€1.9m€1.9m€1.9m▲ 1.8%
Non-distributable reserves130/1-€800,000€800,000€800,000€800,000=
Reserves not available under the articles1311--€800,000€800,000€800,000=
Financial assistance1313-€800,000----
Tax-exempt reserves132-€190,040€152,150€126,300€159,407▲ 26.2%
Distributable reserves133-€891,360€992,400€931,400€931,400=
Profit (loss) carried forward14€21,443€177€2,808€20,794€7,065▼ 66.0%
Amounts payable17/49€942,415€471,844€593,509€626,802€356,010▼ 43.2%
Amounts payable within one year42/48€940,888€465,591€593,509€626,802€356,010▼ 43.2%
Trade debts44€66,974€136,545€160,183€240,640€107,734▼ 55.2%
Suppliers440/4-€136,545€160,183€240,132€107,734▼ 55.1%
Bills of exchange payable441---€507--
Advances received on contracts in progress46--€31,651€1,621--
Taxes, remuneration and social security45-€163,672€117,602€141,522€202,773▲ 43.3%
Taxes450/3-€50,515€34,217€41,364€51,789▲ 25.2%
Remuneration and social security454/9-€113,157€83,385€100,159€150,984▲ 50.7%
Other amounts payable47/48-€165,374€284,073€243,019€45,504▼ 81.3%
Accrued charges and deferred income492/3-€6,253----
Line20212022202320242025Change
Profit (loss) for the period9904€705,655€176,576€368,819€174,155€64,882▼ 62.7%
+ Depreciation and write-downs630€454€227€484€1,512€1,548▲ 2.4%
Operating cash flow (approximation)€706,109€176,803€369,303€175,667€66,430▼ 62.2%
Investment in fixed assets (approximation)--€800,000-€6,418€797,356€0▼ 100%
Change in cash--€1.5m-€367,702-€84,573€109,310▲ 229%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-01-2027
2026
03-08
State Gazette act Resignations: MEULEMAN Philippe Charles Louis (director) and BERNARD Guy Ivan Marc (director)
Appointment: AMARRIS HOLDING.BE (non-statutory director) · Permanent representative: ROBIN Claude Gilbert André · Reappointment: CDP PETIT & Co SRL (statutory auditor)20 facts ▸
  • General meeting, 30-06-2026
  • Other statement, première résolution - rapport spécial organe d’administration justification modification objet, sans réserves
  • Purpose change
  • Statutes amendment
  • Other statement, inscription registre public ITAA, personne morale reconnue comme société d’expert-comptable certifié
  • Capital
  • Other statement, TITRE IV : ADMINISTRATION - CONTROLE, titre statutaire
  • Director resignation, MEULEMAN Philippe Charles Louis (director)
  • Director resignation, BERNARD Guy Ivan Marc (director)
  • Director discharge, MEULEMAN Philippe Charles Louis
  • Director discharge, BERNARD Guy Ivan Marc
  • Board rule, 1
  • +8 further facts in this act
08-01
NBB filing Annual accounts filed
fiscal year 2025 · full schema
2025
30-06
Financial Weakest financial yearnet €64,882 ▼62.7%
Net result drops to €64,882, the lowest in the series.
2024
19-12
NBB filing Annual accounts filed
fiscal year 2024 · full schema
25-04
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
25-01
NBB filing Annual accounts filed
fiscal year 2023 · full schema
2022
23-12
NBB filing Annual accounts filed
fiscal year 2022 · full schema
28-03
NBB filing Annual accounts filed
fiscal year 2021 · full schema
2021
31-12
Financial Highest result since 2018net €705,655 ▲39.1%
Operating result €914,870, net result €705,655, both a record.
31-05
NBB filing Annual accounts filed
fiscal year 2020 · full schema
2020
16-07
NBB filing Annual accounts filed
fiscal year 2019 · full schema
2019
29-03
NBB filing Annual accounts filed
fiscal year 2018 · full schema
2018
27-06
NBB filing Annual accounts filed
fiscal year 2017 · full schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
1 of 5 acts read
About the unread acts

Of the 5 Belgian State Gazette acts we know for this company, 1 has been read. The other 4 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
1 director, last change in 2026

Board 1

AMARRIS HOLDING.BE
Non-statutory director · since 03-08-2026 · Legal entity · perm. rep.: ROBIN Claude Gilbert André
Current

Permanent representatives 1

ROBIN Claude Gilbert André
Permanent representative · since 03-08-2026 · for AMARRIS HOLDING.BE
Current

Statutory auditor 1

CDP PETIT & Co
Auditor · since 03-08-2026 · perm. rep.: GORLIER Benjamin
Current
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ. See the function holders in the CBE →
Not every act has been read: a resignation may be missing here
4 of this company's 5 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Liège · 1 establishment unit since 2000
seat establishment The establishment unit on the map
Ground area
405 m²
Building footprint
207 m²
Volume, LiDAR
1,699 m³
Parcel 62817B0289/00P003, Wallonia · tallest building 8.8 m, ±3 floors. Linked by address, not a title deed.
11 companies at this address See who is registered here
1 establishment unit
Pharmalex
Rue de Mulhouse 33, 4020 LiègeNACE 74122
since 20002.229.125.029
1 parcel
Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
62817B0289/00P003 Wallonia 405 m² 1 · 207 m² 8.8 m · 3 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Mandate history

4 people since 2026, 2 in office
Show
  • Board
  • Statutory auditor
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
AMARRIS HOLDING.BE
  • Non-statutory director, from 03-08-2026 to date
CDP PETIT & Co
  • Auditor, from 03-08-2026 to date
BERNARD Guy Ivan Marc
  • Director, until 03-08-2026
MEULEMAN Philippe Charles Louis
  • Director, until 03-08-2026
See the board, name and seat on a given date →

Articles of association

Annual meeting
Second Friday of December at 17:00
Purpose
L'organisation de la comptabilité et des services comptables et les activités de conseil en matière d'organisation comptable des entreprises; La détermination des résultats et…
Full purpose (12 activities)
  1. L'organisation de la comptabilité et des services comptables et les activités de conseil en matière d'organisation comptable des entreprises;
  2. La détermination des résultats et l'établissement des comptes annuels conformément aux dispositions légales en la matière;
  3. L'ouverture, la tenue, la centralisation et la clôture des écritures comptables propres à l'établissement des comptes;
  4. La vérification et le redressement de tous les documents comptables qui ne conduisent pas à une attestation ou un rapport d'expertise destinés à être remis à des tiers;
  5. L'analyse par les procédés de la technique comptable de la situation et du fonctionnement des entreprises du point de vue de leur crédit, de leur rendement et de leurs risques qui ne conduit pas à une attestation ou un rapport d'expertise destinés à être remis à des tiers;
  6. L'expertise, tant privée que judiciaire, dans le domaine de la comptabilité des entreprises;
  7. Toute mission visée aux 4° à 6° exercée par un expert-comptable certifié autre que le professionnel habituel qui conduit à une attestation ou un rapport d'expertise destinés à être remis à des tiers;
  8. Les autres missions dont l'accomplissement est réservé par la loi ou en vertu de la loi à l'expert-comptable certifié;
  9. La délivrance d'avis se rapportant à toutes matières fiscales;
  10. L'assistance du contribuable dans l'accomplissement de ses obligations fiscales;
  11. La représentation du contribuable auprès de l'administration fiscale;
  12. L'organisation des services administratifs et le conseil sur l'organisation administrative des entreprises.
Registered office clause
Article 2, par simple décision organe d’administration établir ou supprimer sièges administratifs, agences, ateliers, dépôts et succursales tant en Belgique qu’…
Other statement
Appels de fonds, après second avis recommandé resté sans résultat pendant un (1) mois,convocation assemblée pour prononcer exclusion conformément CSA
Administrateur peut mandater autre membre pour réunion donnée par pièce signée y compris signature digitale article 8.1 3° Code civil communiquée lettre/fax/cou…
Rémunération des administrateurs, Article 14
Article 15. Gestion journalière
Contrôle de la société, Article 16
TITRE V : ASSEMBLEE GENERALE, tenue et convocation assemblée générale
Article 18. Convocations – Admission
Séances procès-verbaux assemblée générale, un ou plusieurs membres organe d'administration ayant pouvoir de représentation
Chaque action une voix sous réserve actions sans droit de vote, délibérations assemblée générale
Article 21. Prorogation
Communication électronique mis à disposition par société, participation électronique distance visioconférence
Article 24. Répartition – réserves
Élection de domicile, au siège où communications sommations assignations significations valablement faites
Article 29. Compétence judicaire
Droit commun, dispositions statutaires non conformes dispositions impératives Code des sociétés et des associations règlementation profession règles déontologiq…
Share issue rule
Apport en numéraire avec émission de nouvelles actions-droit de préférence, courrier électronique,ou courrier ordinaire même jour si pas d’adresse électronique
Share class
Article 8. Nature des actions
Membership rule
Qualité d’actionnaire société d’expert-comptable certifié, Conseil de l’Institut
Transfer restriction
Droits de vote entre vifs et pour cause de mort, majorité des droits de vote détenue par experts-comptables certifiés et/ou équivalents autre Etat membre
Board rule
Organe d'administration, Article 11
Dissolution rule
Tout temps par assemblée générale délibérant formes modifications aux statuts
Liquidation rule
Article 26. Liquidateurs
Liquidation distribution
Apurement dettes charges frais ou consignation montants nécessaires, actif net entre tous actionnaires en proportion actions biens conservés remis partagés même…

Structure & network

Owners and holdings

1 owner

Chain of control

  1. AMARRIS HOLDING.BE 100%
  2. PHARMALEX

Highest known parent: AMARRIS HOLDING.BE. The sources do not say who stands above it.

Owners 1

Holdings 0

No holding stated in the accounts, acts or LEI register we read.

According to the annual accounts of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

1 current director
Depth

The network starts from this company’s directors. Other companies they run appear here as nodes.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, scroll to zoom.

Recognitions · licences · registrations

Legal Entity Identifier

254900EQJZJ5K3J26X18
no longer live in the LEI register

Similar companies · same sector, comparable size

Of 12,174 companies in sector 69201 we hold annual accounts for 7,641. 3,155 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded19-05-2000
Fiscal year end30-06
Activities, NACEBEL 2025
69201Certified accountants and tax accountants
Contact
Phone 04 342 88 00Liège
Fax 04 342 01 13Liège
E-invoicing
Reachable via Peppol
Peppol ID 0208:0471925883
Also 9925:BE0471925883
Registered 31-10-2025

Register as of 27 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.